Related terms
- Transcranial photobiomodulationtPBM
- Light, usually near-infrared, shone through the scalp and skull toward the brain. It is being studied for memory, stroke, brain injury and mood. How much light actually reaches brain tissue is an active research question.
- Pilot study
- A small early study that tests whether an approach is feasible. It can suggest ideas worth testing, but it is rarely large enough to show that a treatment works.
Research that mentions alzheimer’s disease
54 studies in our archive have this term in the title. The newest are below.
From pathogenesis to non-medical therapy: A review of exploring sensory and multi-sensory stimulation as a non-invasive treatment approach for Alzheimer's disease
Alzheimer's disease (AD) is a progressive neurodegenerative disorder, marked by the accumulation of amyloid-beta plaques, tau pathology, and synaptic dysfunction, ultimately leading to memory loss, cognitive decline, neuropsychiatric symptoms and neuronal degeneration that impairs daily functioning.
Comparative efficacy of neuromodulation techniques for Alzheimer's disease: a systematic review and network meta-analysis of randomized controlled trials
Neuromodulation interventions demonstrated domain-specific benefits in AD, with no single approach showing universal superiority. TPS demonstrated the greatest potential for improving global cognitive outcomes, while rTMS showed advantages in ADAS-Cog performance.
Spectral and Directed Connectivity EEG Markers for Classifying Alzheimer's Disease, Frontotemporal Dementia, and Healthy Controls with Exploratory Photobiomodulation Case-Study Projection
Overall, the results support the value of spectral and directed connectivity EEG markers for dementia-related EEG characterization, while highlighting the persistent difficulty of AD vs.
Comparative effectiveness of multiple interventions for Alzheimer's disease on ABC syndromes and QoL: A Bayesian network meta-analysis
For QoL, CT and ET were identified as more favorable outcomes. Collectively, each intervention exerts unique merits targeting ABC symptoms and QoL, implying combined pharmacological and non-pharmacological regimens could optimize therapeutic gains for AD management.
Comparative efficacy and safety of photobiomodulation, transcranial direct current stimulation, and repetitive transcranial magnetic stimulation in Alzheimer's disease: a network meta-analysis of randomized controlled trials
PBM tended to rank highest for cognitive improvement with feasibility and safety comparable to tDCS and rTMS in AD.
Frequency-Specific Transcranial Photobiomodulation Elicits Complementary Glial Mechanisms for Neurovascular Protection and Amyloid Clearance in Alzheimer Disease
These findings reveal complementary pathways for tPBM in AD intervention, highlighting that CW and 40-Hz light offer modality-specific therapeutic advantages: The former targets cerebrovascular dysfunction, while the latter addresses Aβ plaque deposition.
Read this with care
- This entry is general information, not medical advice. See the disclaimer.
- Definitions are written for readers new to the field and may be simplified. Check the full paper when it matters.
- Found a mistake? Tell us.